Clinical Efficacy of Apple Polyphenol for Treating Cedar Pollinosis

DOI Web Site Web Site PubMed 被引用文献5件 参考文献23件
  • KISHI Kazumasa
    Otsu Nutraceutical Research Institute, Otsuka Pharmaceutical Co., Ltd.
  • SAITO Masahiro
    Otsu Nutraceutical Research Institute, Otsuka Pharmaceutical Co., Ltd.
  • SAITO Takao
    Otsu Nutraceutical Research Institute, Otsuka Pharmaceutical Co., Ltd.
  • KUMEMURA Megumi
    Otsu Nutraceutical Research Institute, Otsuka Pharmaceutical Co., Ltd.
  • OKAMATSU Hiroshi
    Otsu Nutraceutical Research Institute, Otsuka Pharmaceutical Co., Ltd.
  • OKITA Misa
    Third Department of Internal Medicine, Tokyo Medical University
  • TAKAZAWA Kenji
    Second Department of Internal Medicine, Tokyo Medical University

この論文をさがす

抄録

A double-blind comparative study was conducted on cedar pollinosis patients in order to evaluate the treatment efficacy of apple polyphenol (Ap). Ap was administered (500 mg) once daily for 12 weeks, starting about 2 weeks prior to cedar pollen dispersion. Pollinosis symptoms during the study were evaluated according to the classification in the guidelines for allergic rhinitis diagnosis and treatment. The results show that the sneezing score was significantly lower for the Ap group than with the placebo group during the early period of pollen dispersion and during the main dispersion period. In addition, no adverse reactions were induced by Ap during the study. These results suggest that Ap may alleviate the symptoms of cedar pollinosis.

収録刊行物

被引用文献 (5)*注記

もっと見る

参考文献 (23)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ